share_log

4: Statement of changes in beneficial ownership of securities-Director TOOVEY STEPHEN

SEC announcement ·  May 22 08:25
Summary by Futu AI
Stephen Toovey, reported a purchase of 4,000 shares of 60 Degrees Pharmaceuticals (SXTP) common stock on May 16, 2024. The transaction was completed at a price of $0.223 per share. Following this acquisition, Toovey's direct holdings in the company increased to a total of 14,000 shares. The transaction, described as a grant, award, or other acquisition, reflects Toovey's growing stake in the pharmaceutical company.
Stephen Toovey, reported a purchase of 4,000 shares of 60 Degrees Pharmaceuticals (SXTP) common stock on May 16, 2024. The transaction was completed at a price of $0.223 per share. Following this acquisition, Toovey's direct holdings in the company increased to a total of 14,000 shares. The transaction, described as a grant, award, or other acquisition, reflects Toovey's growing stake in the pharmaceutical company.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.